NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|2705737217|ref|WP_338033661|]
View 

NAD(P)H-dependent oxidoreductase [Leptothrix cholodnii]

Protein Classification

NAD(P)H-dependent oxidoreductase( domain architecture ID 10006206)

NAD(P)H-dependent oxidoreductase which catalyzes the reduction or oxidation of a substrate coupled to the oxidation or reduction, respectively, of a nicotinamide adenine dinucleotide cofactor NAD(P)H or NAD(P)+

CATH:  3.40.50.360
EC:  1.-.-.-
PubMed:  25372605|7568029
SCOP:  3001217

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
28-200 6.49e-53

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


:

Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 168.86  E-value: 6.49e-53
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  28 HVLVLVAHPDlrRSRVNRRLKQRGQAAARSAP-GIEVRDLYAL-YP------------DFTIDVGAEQAAAAAADLIVWV 93
Cdd:COG2249     1 KILIIYAHPD--PSSFNAALAEAAAEGLEAAGhEVTVHDLYAEgFDpvlsaadfyrdgPLPIDVAAEQELLLWADHLVFQ 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  94 HPIQWYAMPALMKLWVDEVLSLGWAYGPGGR----ALAGKDLWLVTSTGARQEAYHPSGYNRHFFDAFLppyEQTAALCG 169
Cdd:COG2249    79 FPLWWYSMPALLKGWIDRVLTPGFAYGYGGGypggLLKGKKALLVVTTGGPEEAYSRLGYGGPIEELLF---RGTLGYCG 155
                         170       180       190
                  ....*....|....*....|....*....|.
gi 2705737217 170 LRFLPPLVLHGAHVASADELDSHAALFGQRI 200
Cdd:COG2249   156 MKVLPPFVLYGVDRSSDEERAAWLERVRELL 186
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
28-200 6.49e-53

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 168.86  E-value: 6.49e-53
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  28 HVLVLVAHPDlrRSRVNRRLKQRGQAAARSAP-GIEVRDLYAL-YP------------DFTIDVGAEQAAAAAADLIVWV 93
Cdd:COG2249     1 KILIIYAHPD--PSSFNAALAEAAAEGLEAAGhEVTVHDLYAEgFDpvlsaadfyrdgPLPIDVAAEQELLLWADHLVFQ 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  94 HPIQWYAMPALMKLWVDEVLSLGWAYGPGGR----ALAGKDLWLVTSTGARQEAYHPSGYNRHFFDAFLppyEQTAALCG 169
Cdd:COG2249    79 FPLWWYSMPALLKGWIDRVLTPGFAYGYGGGypggLLKGKKALLVVTTGGPEEAYSRLGYGGPIEELLF---RGTLGYCG 155
                         170       180       190
                  ....*....|....*....|....*....|.
gi 2705737217 170 LRFLPPLVLHGAHVASADELDSHAALFGQRI 200
Cdd:COG2249   156 MKVLPPFVLYGVDRSSDEERAAWLERVRELL 186
PRK04930 PRK04930
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
27-198 4.82e-52

glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional


Pssm-ID: 179895 [Multi-domain]  Cd Length: 184  Bit Score: 166.33  E-value: 4.82e-52
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  27 PHVLVLVAHPDLRRSRVNRRLKQrgqaAARSAPGIEVRDLYALYPDFTIDVGAEQAAAAAADLIVWVHPIQWYAMPALMK 106
Cdd:PRK04930    6 PKVLLLYAHPESQDSVANRVLLK----PAQQLEHVTVHDLYAHYPDFFIDIPHEQALLREHDVIVFQHPLYTYSCPALLK 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217 107 LWVDEVLSLGWAYGPGGRALAGKDLWLVTSTGARQEAYHPSGYNRHFFDAFLPPYEQTAALCGLRFLPPLVLHGAHVASA 186
Cdd:PRK04930   82 EWLDRVLSRGFASGPGGNALAGKYWRSVITTGEPESAYRYDGYNRYPMSDILRPFELTAAMCRMHWLSPIIIYWARRQSP 161
                         170
                  ....*....|..
gi 2705737217 187 DELDSHAALFGQ 198
Cdd:PRK04930  162 EELASHARAYGD 173
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
28-200 1.10e-44

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 147.87  E-value: 1.10e-44
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  28 HVLVLVAHPDLRRsrVNRRLKQRGQAAARSAPG-IEVRDLYAL--------------YPDFTIDVGAEQAAAAAADLIVW 92
Cdd:pfam02525   2 KILIINAHPRPGS--FSSRLADALVEALKAAGHeVTVRDLYALflpvldaedladltYPQGAADVESEQEELLAADVIVF 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  93 VHPIQWYAMPALMKLWVDEVLSLGWAY-----GPGGRALAGKDLWLVTSTGARQEAYHPSGYNRHFFDAFLPPYEQTAAL 167
Cdd:pfam02525  80 QFPLYWFSVPALLKGWIDRVLRAGFAFkyeegGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYNGFSLDELLPYLRGILGF 159
                         170       180       190
                  ....*....|....*....|....*....|....
gi 2705737217 168 CGLRFLPPLVLHGAHVASADE-LDSHAALFGQRI 200
Cdd:pfam02525 160 CGITDLPPFAVEGTAGPEDEAaLAEALERYEERL 193
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
28-200 6.49e-53

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 168.86  E-value: 6.49e-53
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  28 HVLVLVAHPDlrRSRVNRRLKQRGQAAARSAP-GIEVRDLYAL-YP------------DFTIDVGAEQAAAAAADLIVWV 93
Cdd:COG2249     1 KILIIYAHPD--PSSFNAALAEAAAEGLEAAGhEVTVHDLYAEgFDpvlsaadfyrdgPLPIDVAAEQELLLWADHLVFQ 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  94 HPIQWYAMPALMKLWVDEVLSLGWAYGPGGR----ALAGKDLWLVTSTGARQEAYHPSGYNRHFFDAFLppyEQTAALCG 169
Cdd:COG2249    79 FPLWWYSMPALLKGWIDRVLTPGFAYGYGGGypggLLKGKKALLVVTTGGPEEAYSRLGYGGPIEELLF---RGTLGYCG 155
                         170       180       190
                  ....*....|....*....|....*....|.
gi 2705737217 170 LRFLPPLVLHGAHVASADELDSHAALFGQRI 200
Cdd:COG2249   156 MKVLPPFVLYGVDRSSDEERAAWLERVRELL 186
PRK04930 PRK04930
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
27-198 4.82e-52

glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional


Pssm-ID: 179895 [Multi-domain]  Cd Length: 184  Bit Score: 166.33  E-value: 4.82e-52
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  27 PHVLVLVAHPDLRRSRVNRRLKQrgqaAARSAPGIEVRDLYALYPDFTIDVGAEQAAAAAADLIVWVHPIQWYAMPALMK 106
Cdd:PRK04930    6 PKVLLLYAHPESQDSVANRVLLK----PAQQLEHVTVHDLYAHYPDFFIDIPHEQALLREHDVIVFQHPLYTYSCPALLK 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217 107 LWVDEVLSLGWAYGPGGRALAGKDLWLVTSTGARQEAYHPSGYNRHFFDAFLPPYEQTAALCGLRFLPPLVLHGAHVASA 186
Cdd:PRK04930   82 EWLDRVLSRGFASGPGGNALAGKYWRSVITTGEPESAYRYDGYNRYPMSDILRPFELTAAMCRMHWLSPIIIYWARRQSP 161
                         170
                  ....*....|..
gi 2705737217 187 DELDSHAALFGQ 198
Cdd:PRK04930  162 EELASHARAYGD 173
PRK00871 PRK00871
glutathione-regulated potassium-efflux system oxidoreductase KefF;
29-208 7.16e-48

glutathione-regulated potassium-efflux system oxidoreductase KefF;


Pssm-ID: 234852  Cd Length: 176  Bit Score: 155.71  E-value: 7.16e-48
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  29 VLVLVAHPDLRRSRVNRRLKQrgqaAARSAPGIEVRDLYALYPDFTIDVGAEQAAAAAADLIVWVHPIQWYAMPALMKLW 108
Cdd:PRK00871    2 ILIIYAHPYPHHSHANKRMLE----QARTLEGVEIRSLYQLYPDFNIDIAAEQEALSRADLIVWQHPMQWYSIPPLLKLW 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217 109 VDEVLSLGWAYGPGGRALAGKD-LWLVTSTGarqEAYHPSGYNRHFFDAFLPPYEQTAALCGLRFLPPLVLHGAHVASAD 187
Cdd:PRK00871   78 IDKVLSHGWAYGHGGTALHGKHlLWAVTTGG---GESHFEIGAHPGFDVLSQPLQATALYCGLNWLPPFAMHCTFICDDE 154
                         170       180
                  ....*....|....*....|.
gi 2705737217 188 ELDSHAALFGQRILshpDWPE 208
Cdd:PRK00871  155 TLEGQARHYKQRLL---EWQE 172
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
28-200 1.10e-44

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 147.87  E-value: 1.10e-44
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  28 HVLVLVAHPDLRRsrVNRRLKQRGQAAARSAPG-IEVRDLYAL--------------YPDFTIDVGAEQAAAAAADLIVW 92
Cdd:pfam02525   2 KILIINAHPRPGS--FSSRLADALVEALKAAGHeVTVRDLYALflpvldaedladltYPQGAADVESEQEELLAADVIVF 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  93 VHPIQWYAMPALMKLWVDEVLSLGWAY-----GPGGRALAGKDLWLVTSTGARQEAYHPSGYNRHFFDAFLPPYEQTAAL 167
Cdd:pfam02525  80 QFPLYWFSVPALLKGWIDRVLRAGFAFkyeegGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYNGFSLDELLPYLRGILGF 159
                         170       180       190
                  ....*....|....*....|....*....|....
gi 2705737217 168 CGLRFLPPLVLHGAHVASADE-LDSHAALFGQRI 200
Cdd:pfam02525 160 CGITDLPPFAVEGTAGPEDEAaLAEALERYEERL 193
PRK09739 PRK09739
NAD(P)H oxidoreductase;
27-151 9.10e-09

NAD(P)H oxidoreductase;


Pssm-ID: 236620 [Multi-domain]  Cd Length: 199  Bit Score: 53.55  E-value: 9.10e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2705737217  27 PHVLVLVAHP--DLRRSRVNRRLKQRGQAAARSapgIEVRDLY------ALY----PDFTI-------DVGAEQAAAAAA 87
Cdd:PRK09739    4 MRIYLVWAHPrhDSLTAKVAEAIHQRAQERGHQ---VEELDLYrsgfdpVLTpedePDWKNpdkryspEVHQLYSELLEH 80
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2705737217  88 DLIVWVHPIQWYAMPALMKLWVDEVLSLGWAYGPGGRALAGKDLWLVTStGARQEAYHPSGYNR 151
Cdd:PRK09739   81 DALVFVFPLWWYSFPAMLKGYIDRVWNNGLAYGDGHKLPFNKVRWVALV-GGSKESFVKRGWEK 143
WrbA COG0655
Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and ...
88-140 3.99e-04

Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and conversion];


Pssm-ID: 440420 [Multi-domain]  Cd Length: 181  Bit Score: 39.91  E-value: 3.99e-04
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|...
gi 2705737217  88 DLIVWVHPIQWYAMPALMKLWVDEVLSLgWAygpGGRALAGKDLWLVTSTGAR 140
Cdd:COG0655    72 DGIIFGSPTYFGNMSAQLKAFIDRLYAL-WA---KGKLLKGKVGAVFTTGGHG 120
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH